AI Article Synopsis

  • Management of anticoagulants during polypectomy remains debated, with cold snare polypectomy (CSP) showing lower bleeding risks compared to hot snare polypectomy (HSP).
  • The study aimed to evaluate the safety and effectiveness of continuous anticoagulant administration with CSP versus periprocedural heparin bridging with HSP in patients with small colorectal polyps.
  • Results indicated that major bleeding incidents were significantly lower in the CA+CSP group (4.7%) compared to the HB+HSP group (12.0%), supporting the noninferiority of CSP when managing anticoagulated patients.

Article Abstract

Background: Management of anticoagulants for patients undergoing polypectomy is still controversial. Cold snare polypectomy (CSP) is reported to cause less bleeding than hot snare polypectomy (HSP).

Objective: To compare outcomes between continuous administration of anticoagulants (CA) with CSP (CA+CSP) and periprocedural heparin bridging (HB) with HSP (HB+HSP) for subcentimeter colorectal polyps.

Design: Multicenter, parallel, noninferiority randomized controlled trial. (University Hospital Medical Information Network Clinical Trials Registry: UMIN000019355).

Setting: 30 Japanese institutions.

Patients: Patients receiving anticoagulant therapy (warfarin or direct oral anticoagulants) who had at least 1 nonpedunculated subcentimeter colorectal polyp.

Intervention: Patients were randomly assigned to undergo HB+HSP or CA+CSP and followed up 28 days after polypectomy.

Measurements: The primary end point was incidence of polypectomy-related major bleeding (based on the incidence of poorly controlled intraprocedural bleeding or postpolypectomy bleeding requiring endoscopic hemostasis). The prespecified inferiority margin was -5% (CA+CSP vs. HB+HSP).

Results: A total of 184 patients were enrolled: 90 in the HB+HSP group, 92 in the CA+CSP group, and 2 who declined to participate after enrollment. The incidence of polypectomy-related major bleeding in the HB+HSP and CA+CSP groups was 12.0% (95% CI, 5.0% to 19.1%) and 4.7% (CI, 0.2% to 9.2%), respectively. The intergroup difference for the primary end point was +7.3% (CI, -1.0% to 15.7%), with a 0.4% lower limit of 2-sided 90% CI, demonstrating the noninferiority of CA+CSP. The mean procedure time for each polyp and the hospitalization period were longer in the HB+HSP than in the CA+CSP group.

Limitation: An open-label trial assessing 2 factors (anticoagulation approach and polypectomy procedure type) simultaneously.

Conclusion: Patients having CA+CSP for subcentimeter colorectal polyps who were receiving oral anticoagulants did not have an increased incidence of polypectomy-related major bleeding, and procedure time and hospitalization were shorter than in those having HB+HSP.

Primary Funding Source: Japanese Gastroenterological Association.

Download full-text PDF

Source
http://dx.doi.org/10.7326/M19-0026DOI Listing

Publication Analysis

Top Keywords

snare polypectomy
16
subcentimeter colorectal
12
hb+hsp ca+csp
12
incidence polypectomy-related
12
polypectomy-related major
12
major bleeding
12
cold snare
8
heparin bridging
8
hot snare
8
randomized controlled
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!